---
figid: PMC9066134__43088_2022_245_Fig1_HTML
figtitle: Coinfection of fungi with SARS-CoV-2 is a detrimental health risk for COVID-19
  patients
organisms:
- Saccharomyces cerevisiae
- Candida albicans
- Aspergillus fumigatus
- Aspergillus flavus
- Nakaseomyces glabratus
- Candida tropicalis
- Rhizopus arrhizus
- Candida parapsilosis
- Candida auris
- Pneumocystis jirovecii
- Rhizopus microsporus
- Lichtheimia corymbifera
- Rhizomucor pusillus
- Apophysomyces variabilis
- Severe acute respiratory syndrome coronavirus 2
- Coronaviridae
- Homo sapiens
organisms_ner:
- Homo sapiens
- Drosophila melanogaster
pmcid: PMC9066134
filename: 43088_2022_245_Fig1_HTML.jpg
figlink: /pmc/articles/PMC9066134/figure/Fig1/
number: F1
caption: 'An overview of how fungi take the chances of the hampered immune system
  caused by SARS-CoV-2. Innate immune response in SARS-CoV-2 infection: SARS-CoV-2
  enter the host cell through the attachment of viral spike (S) protein to ACE-2 (angiotensin-converting
  enzyme-2) receptor on the cell membrane (1). Then ssRNA virus is reassembled to
  the dsRNA viral genome (2). TLR-3 (Toll-like receptor-3) mutation stops the NF-κβ
  (nuclear factor kappa-light-chain-enhancer of activated B cells) pathway and prevents
  the release of cytokines and chemokines (3). Macrophage releases IL-6, IL-10, IL-12,
  IL-18, IL1-β, and TNF-α (4). Antigen-presenting cells (APC) present MHC II (major
  histocompatibility complex II) peptide complex on T cells (5, 6). Adaptive immune
  response in SARS-CoV-2 infection: TH1/CD8 + and TH2/CD4 + release IFN-γ, TNF-α,
  IL-10, and IL-17 (7, 8). TH2 releases antibodies followed by activating B-cell (9,
  10). Antibodies activate NK (natural killer) cells to release cytokines and chemokines
  (11, 12). Innate immune response in fungal infection after SARS-CoV-2 infection:
  Fungal complement protein stops the release of IL-6 and TGF-β (13). Fungal pathogens
  activate neutrophils (14). Pathogen attaches by dectin-1 in dendritic cells, and
  destructed immune system fails to release cytokines (15, 16). Pathogen escapes and
  subsequently presents on APC (antigen-presenting cells) with the help of the MHC
  II peptide complex to activate T cells (17, 18). Adaptive immune response in fungal
  infection after SARS-CoV-2 infection: Impaired adaptive immune response having cytokines
  from the “cytokine storm” results in the blockage of the proliferation of T cell
  into TH1/CD8 + and TH2/CD4 + (19, 20)'
papertitle: Coinfection of fungi with SARS-CoV-2 is a detrimental health risk for
  COVID-19 patients.
reftext: Nahida Baten, et al. Beni Suef Univ J Basic Appl Sci. 2022;11(1):64.
year: '2022'
doi: 10.1186/s43088-022-00245-9
journal_title: Beni-Suef University Journal of Basic and Applied Sciences
journal_nlm_ta: Beni Suef Univ J Basic Appl Sci
publisher_name: Springer Berlin Heidelberg
keywords: COVID-19 | SARS-CoV-2 | Fungal coinfection | Mucormycosis | IPA | CAPA
automl_pathway: 0.9491294
figid_alias: PMC9066134__F1
figtype: Figure
redirect_from: /figures/PMC9066134__F1
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC9066134__43088_2022_245_Fig1_HTML.html
  '@type': Dataset
  description: 'An overview of how fungi take the chances of the hampered immune system
    caused by SARS-CoV-2. Innate immune response in SARS-CoV-2 infection: SARS-CoV-2
    enter the host cell through the attachment of viral spike (S) protein to ACE-2
    (angiotensin-converting enzyme-2) receptor on the cell membrane (1). Then ssRNA
    virus is reassembled to the dsRNA viral genome (2). TLR-3 (Toll-like receptor-3)
    mutation stops the NF-κβ (nuclear factor kappa-light-chain-enhancer of activated
    B cells) pathway and prevents the release of cytokines and chemokines (3). Macrophage
    releases IL-6, IL-10, IL-12, IL-18, IL1-β, and TNF-α (4). Antigen-presenting cells
    (APC) present MHC II (major histocompatibility complex II) peptide complex on
    T cells (5, 6). Adaptive immune response in SARS-CoV-2 infection: TH1/CD8 + and
    TH2/CD4 + release IFN-γ, TNF-α, IL-10, and IL-17 (7, 8). TH2 releases antibodies
    followed by activating B-cell (9, 10). Antibodies activate NK (natural killer)
    cells to release cytokines and chemokines (11, 12). Innate immune response in
    fungal infection after SARS-CoV-2 infection: Fungal complement protein stops the
    release of IL-6 and TGF-β (13). Fungal pathogens activate neutrophils (14). Pathogen
    attaches by dectin-1 in dendritic cells, and destructed immune system fails to
    release cytokines (15, 16). Pathogen escapes and subsequently presents on APC
    (antigen-presenting cells) with the help of the MHC II peptide complex to activate
    T cells (17, 18). Adaptive immune response in fungal infection after SARS-CoV-2
    infection: Impaired adaptive immune response having cytokines from the “cytokine
    storm” results in the blockage of the proliferation of T cell into TH1/CD8 + and
    TH2/CD4 + (19, 20)'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - PER1
  - APC
  - PROC
  - HLA-C
  - CD8A
  - CD8B
  - ACE2
  - IL17A
  - CD4
  - IFNA1
  - TNF
  - RPL18
  - IGKV1D-13
  - IGKV1-13
  - BOC
  - TNFRSF10B
  - IL10
  - CXCL10
  - CXCL11
  - CXCL12
  - CXCL13
  - CXCL14
  - CXCL9
  - PF4
  - CXCL1
  - CXCL2
  - CXCL3
  - CXCL5
  - CXCL6
  - CXCL8
  - PPBP
  - MAP6
  - IL4
  - IL12A
  - IL12B
  - LINC00689
  - IL6
  - IL1B
  - IL18
  - CLEC7A
  - per
  - Apc
  - Apc2
  - Axn
  - Fs(3)Apc
  - ca
  - Tl
  - Sod1
  - Mhc
  - zip
  - thi
  - thiv
  - Ace
  - egr
  - pat
  - ptc
  - RpL18A
  - l(1)L18
  - RpL5
  - bol
  - boi
  - stop
  - JIL-1
---
